Skip to main content
Premium Trial:

Request an Annual Quote

HHS Agencies Offering New SBIR Grants

NEW YORK (GenomeWeb News) — Several branches of the Department of Health and Human Services have invited eligible businesses to apply for Small Business Innovation Research grants, according to the National Institutes of Health.

The new SBIR grants will be made by NIH, the Food and Drug Administration, the Centers for Disease Control and Prevention, and the Administration for Children and Families.

Small business concerns in the US that have the research capabilities and technological expertise may apply for Phase I or Phase II funding. Phase I grants are designed to establish the technical/scientific merit and feasibility of the proposed studies, and offer up to $100,000 for a period that is normally less than six months.

The aim of Phase II grants is to continue the research and development efforts begun in Phase I, and they may provide up to $750,000 for two years. The second phase grant award levels and project periods are "statutory guidelines, not ceilings," NIH said in the announcement.

The SBIR program is intended to stimulate technological innovation in the private sector; strengthen the role of small business in meeting research needs; increase the commercial application of Federally-supported research results; foster and encourage participations by socially and economically disadvantaged small business concerns and women-owned business concerns in the SBIR program; and improve the return on investment from federally-funded research that benefits the nation.

More information about the SBIR funding is available here.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.